Better to Treat Rheumatoid Arthritis in its Early Stages
EULAR 2017: Undifferentiated arthritis or very early rheumatoid arthritis should be treated soon after diagnosis to prevent advanced arthritis.
Romosozumab Continues to Build Bone, Reduce Fracture Risk
EULAR 2017: Romosozumab reduces the risk of clinical vertebral fractures in postmenopausal women with osteoporosis by as much as five times.
The Promise of New Therapies in PsA and AxSpA
Two-three percent of people in the general population live with psoriatic arthritis, but many of them go undiagnosed, says Dr. Christopher Ritchlin, who recently spoke at RNS16.
OA Pathology Linked to New Biomarkers
Spanish researchers have uncovered evidence that may be indicative of solid biomarkers for osteoarthritis. Researchers reported their findings at the OARSI 2016 World Congress held in Amsterdam this month.
Only Minimal Pain Relief from VitD for Knee Pain
Vitamin D doesn't offer much osteoarthritis pain relief. Knee pain, physical function, bone marrow lesions and effusion-synovitism show little improvements, shows a study presented at OARSI 2016.
Study Reveals a Link between Heart Disease and Knee OA
Severe knee osteoarthritis is modestly associated with an increased risk of all-cause and cardiovascular disease specific mortality, a study presented at OARSI 2016 shows.
Study: This Corticosteroid Reduces OA Pain
For osteoarthritis patients in pain, this corticosteriod provides sustained and "highly effective" pain relief, study presented at OARSI 2016 shows.
By clicking Accept, you agree to become a member of the UBM Medica Community.